Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction

  • Technology appraisal guidance
  • TA388
  • Published: 
Download (PDF)

Why has NICE said this?

Sacubitril valsartan was recommended because the benefits to patients justify its cost.

NICE looks at how well treatments work in relation to how much they cost compared with other treatments available on the NHS.

  • Information Standard